Framework agreement for the supply of sacituzumab govitecan 200 mg

Summary

The tender is for the supply of a medicine containing sacituzumab govitecan 200 mg under a 24-month framework agreement. The quantity is 500–2,000 vials and the framework agreement ceiling is RON 9,642,580; the contracting authority may select up to three suppliers for the framework agreement. Deliveries will be made to the hospital pharmacy specified on each order form. Price is the only award criterion, and a new price offer will be requested to resolve a tie. Bids must be submitted electronically through SEAP by 15:00 on 4 November 2026. Bidders must submit the European Single Procurement Document (ESPD) and prove that they are legally registered and authorised to supply the medicines; the exclusion grounds and supporting evidence are summarised below. Invoices are payable within a maximum of 60 days of receipt. The lot description mentions a RON 482.13 tender guarantee, but another notice field states that no guarantee is required; bidders should verify the applicable requirement in the tender documents.